Do analysts rate ROCG or STI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Roth CH Acquisition IV 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Solidion Technology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable valuation & earnings, ROCG or STI?

Roth CH Acquisition IV has higher earnings, but lower revenue than Solidion Technology. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Roth CH Acquisition IV N/A N/A -$180K N/A N/A Solidion Technology $10K 5,633.62 -$41M -$12.85 N/A

Is ROCG or STI more profitable?

Solidion Technology's return on equity of 0.00% beat Roth CH Acquisition IV's return on equity. Company Net Margins Return on Equity Return on Assets Roth CH Acquisition IV N/A -6,449.52% -0.66% Solidion Technology N/A N/A -119.29%

Do analysts recommend ROCG or WBX?

Wallbox has a consensus target price of $4.33, indicating a potential upside of 47.90%. Given Wallbox's stronger consensus rating and higher possible upside, analysts clearly believe Wallbox is more favorable than Roth CH Acquisition IV. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Roth CH Acquisition IV 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Wallbox 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25

Which has better valuation & earnings, ROCG or WBX?

Roth CH Acquisition IV has higher earnings, but lower revenue than Wallbox. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Roth CH Acquisition IV N/A N/A -$180K N/A N/A Wallbox $164.15M 0.31 -$115.14M N/A N/A

Do analysts recommend NMAD or ROCG?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Lixte Biotechnology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Roth CH Acquisition IV 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has stronger valuation & earnings, NMAD or ROCG?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Lixte Biotechnology N/A N/A -$6.01M -$1.00 N/A Roth CH Acquisition IV N/A N/A -$180K N/A N/A

Is NMAD or ROCG more profitable?

Lixte Biotechnology's return on equity of -75.49% beat Roth CH Acquisition IV's return on equity. Company Net Margins Return on Equity Return on Assets Lixte Biotechnology N/A -75.49% -62.03% Roth CH Acquisition IV N/A -6,449.52% -0.66%

Do analysts rate ROCG or FTCI?

FTC Solar has a consensus price target of $8.90, suggesting a potential upside of 232.09%. Given FTC Solar's stronger consensus rating and higher probable upside, analysts clearly believe FTC Solar is more favorable than Roth CH Acquisition IV. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Roth CH Acquisition IV 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 FTC Solar 1 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.50

Which has higher valuation and earnings, ROCG or FTCI?

Roth CH Acquisition IV has higher earnings, but lower revenue than FTC Solar. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Roth CH Acquisition IV N/A N/A -$180K N/A N/A FTC Solar $99.69M 0.44 -$79.58M -$6.25 N/A

Do analysts recommend BEEM or ROCG?

Beam Global presently has a consensus target price of $1.50, suggesting a potential upside of 23.97%. Given Beam Global's stronger consensus rating and higher possible upside, research analysts plainly believe Beam Global is more favorable than Roth CH Acquisition IV. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Beam Global 1 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.25 Roth CH Acquisition IV 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has stronger valuation and earnings, BEEM or ROCG?

Roth CH Acquisition IV has lower revenue, but higher earnings than Beam Global. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Beam Global $28.24M 0.97 -$27M -$0.82 N/A Roth CH Acquisition IV N/A N/A -$180K N/A N/A

Roth CH Acquisition IV (ROCG) Competitors

$0.89 -0.09 (-8.73%)

As of 09/23/2026

Compare

ROCG vs. STI, WBX, NMAD, FTCI, and BEEM

Should you buy Roth CH Acquisition IV stock or one of its competitors? Roth CH Acquisition IV's main competitors and comparable companies include Solidion Technology (STI), Wallbox (WBX), Lixte Biotechnology (NMAD), FTC Solar (FTCI), and Beam Global (BEEM). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "electrical components & equipment" industry.

How does Roth CH Acquisition IV compare to Solidion Technology?

Roth CH Acquisition IV (NASDAQ:ROCG) and Solidion Technology (NASDAQ:STI) are both small-cap industrials companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, profitability, institutional ownership, risk, analyst recommendations, earnings and media sentiment.

Solidion Technology's return on equity of 0.00% beat Roth CH Acquisition IV's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Roth CH Acquisition IV	N/A	-6,449.52%	-0.66%
Solidion Technology	N/A	N/A	-119.29%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Roth CH Acquisition IV	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Solidion Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Solidion Technology had 7 more articles in the media than Roth CH Acquisition IV. MarketBeat recorded 7 mentions for Solidion Technology and 0 mentions for Roth CH Acquisition IV. Solidion Technology's average media sentiment score of 0.27 beat Roth CH Acquisition IV's score of 0.00 indicating that Solidion Technology is being referred to more favorably in the news media.

Company	Overall Sentiment
Roth CH Acquisition IV	Neutral
Solidion Technology	Neutral

Roth CH Acquisition IV has a beta of 0.03, meaning that its stock price is 97% less volatile than the broader market. Comparatively, Solidion Technology has a beta of -0.01, meaning that its stock price is 101% less volatile than the broader market.

67.1% of Roth CH Acquisition IV shares are owned by institutional investors. 29.6% of Roth CH Acquisition IV shares are owned by company insiders. Comparatively, 0.4% of Solidion Technology shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Roth CH Acquisition IV has higher earnings, but lower revenue than Solidion Technology.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Roth CH Acquisition IV	N/A	N/A	-$180K	N/A	N/A
Solidion Technology	$10K	5,633.62	-$41M	-$12.85	N/A

Summary

Roth CH Acquisition IV and Solidion Technology tied by winning 5 of the 10 factors compared between the two stocks.

How does Roth CH Acquisition IV compare to Wallbox?

Roth CH Acquisition IV (NASDAQ:ROCG) and Wallbox (NYSE:WBX) are both small-cap industrials companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, risk, valuation, dividends, earnings, profitability, media sentiment and institutional ownership.

Wallbox has a consensus target price of $4.33, indicating a potential upside of 47.90%. Given Wallbox's stronger consensus rating and higher possible upside, analysts clearly believe Wallbox is more favorable than Roth CH Acquisition IV.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Roth CH Acquisition IV	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Wallbox	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

Roth CH Acquisition IV has a beta of 0.03, indicating that its share price is 97% less volatile than the broader market. Comparatively, Wallbox has a beta of 2.01, indicating that its share price is 101% more volatile than the broader market.

67.1% of Roth CH Acquisition IV shares are held by institutional investors. Comparatively, 36.9% of Wallbox shares are held by institutional investors. 29.6% of Roth CH Acquisition IV shares are held by company insiders. Comparatively, 33.3% of Wallbox shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Roth CH Acquisition IV has higher earnings, but lower revenue than Wallbox.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Roth CH Acquisition IV	N/A	N/A	-$180K	N/A	N/A
Wallbox	$164.15M	0.31	-$115.14M	N/A	N/A

Roth CH Acquisition IV has a net margin of 0.00% compared to Wallbox's net margin of -70.12%. Roth CH Acquisition IV's return on equity of -6,449.52% beat Wallbox's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Roth CH Acquisition IV	N/A	-6,449.52%	-0.66%
Wallbox	-70.12%	-6,451.74%	-55.57%

In the previous week, Wallbox had 2 more articles in the media than Roth CH Acquisition IV. MarketBeat recorded 2 mentions for Wallbox and 0 mentions for Roth CH Acquisition IV. Wallbox's average media sentiment score of 0.37 beat Roth CH Acquisition IV's score of 0.00 indicating that Wallbox is being referred to more favorably in the news media.

Company	Overall Sentiment
Roth CH Acquisition IV	Neutral
Wallbox	Neutral

Summary

Wallbox beats Roth CH Acquisition IV on 8 of the 13 factors compared between the two stocks.

How does Roth CH Acquisition IV compare to Lixte Biotechnology?

Lixte Biotechnology (NASDAQ:NMAD) and Roth CH Acquisition IV (NASDAQ:ROCG) are both small-cap industrials companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, profitability, earnings, risk, analyst recommendations and media sentiment.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lixte Biotechnology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Roth CH Acquisition IV	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

5.1% of Lixte Biotechnology shares are held by institutional investors. Comparatively, 67.1% of Roth CH Acquisition IV shares are held by institutional investors. 7.3% of Lixte Biotechnology shares are held by company insiders. Comparatively, 29.6% of Roth CH Acquisition IV shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Lixte Biotechnology's return on equity of -75.49% beat Roth CH Acquisition IV's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Lixte Biotechnology	N/A	-75.49%	-62.03%
Roth CH Acquisition IV	N/A	-6,449.52%	-0.66%

In the previous week, Lixte Biotechnology had 2 more articles in the media than Roth CH Acquisition IV. MarketBeat recorded 2 mentions for Lixte Biotechnology and 0 mentions for Roth CH Acquisition IV. Lixte Biotechnology's average media sentiment score of 0.35 beat Roth CH Acquisition IV's score of 0.00 indicating that Lixte Biotechnology is being referred to more favorably in the media.

Company	Overall Sentiment
Lixte Biotechnology	Neutral
Roth CH Acquisition IV	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lixte Biotechnology	N/A	N/A	-$6.01M	-$1.00	N/A
Roth CH Acquisition IV	N/A	N/A	-$180K	N/A	N/A

Lixte Biotechnology has a beta of 1.3, suggesting that its stock price is 30% more volatile than the broader market. Comparatively, Roth CH Acquisition IV has a beta of 0.03, suggesting that its stock price is 97% less volatile than the broader market.

Summary

Lixte Biotechnology beats Roth CH Acquisition IV on 5 of the 9 factors compared between the two stocks.

How does Roth CH Acquisition IV compare to FTC Solar?

Roth CH Acquisition IV (NASDAQ:ROCG) and FTC Solar (NASDAQ:FTCI) are both small-cap industrials companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, earnings, media sentiment, analyst recommendations, institutional ownership, profitability, valuation and risk.

67.1% of Roth CH Acquisition IV shares are held by institutional investors. Comparatively, 45.4% of FTC Solar shares are held by institutional investors. 29.6% of Roth CH Acquisition IV shares are held by company insiders. Comparatively, 21.0% of FTC Solar shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Roth CH Acquisition IV has a net margin of 0.00% compared to FTC Solar's net margin of -51.02%. FTC Solar's return on equity of 0.00% beat Roth CH Acquisition IV's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Roth CH Acquisition IV	N/A	-6,449.52%	-0.66%
FTC Solar	-51.02%	N/A	-37.99%

In the previous week, FTC Solar had 3 more articles in the media than Roth CH Acquisition IV. MarketBeat recorded 3 mentions for FTC Solar and 0 mentions for Roth CH Acquisition IV. Roth CH Acquisition IV's average media sentiment score of 0.00 equaled FTC Solar'saverage media sentiment score.

Company	Overall Sentiment
Roth CH Acquisition IV	Neutral
FTC Solar	Neutral

Roth CH Acquisition IV has a beta of 0.03, suggesting that its stock price is 97% less volatile than the broader market. Comparatively, FTC Solar has a beta of 1.84, suggesting that its stock price is 84% more volatile than the broader market.

FTC Solar has a consensus price target of $8.90, suggesting a potential upside of 232.09%. Given FTC Solar's stronger consensus rating and higher probable upside, analysts clearly believe FTC Solar is more favorable than Roth CH Acquisition IV.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Roth CH Acquisition IV	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
FTC Solar	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

Roth CH Acquisition IV has higher earnings, but lower revenue than FTC Solar.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Roth CH Acquisition IV	N/A	N/A	-$180K	N/A	N/A
FTC Solar	$99.69M	0.44	-$79.58M	-$6.25	N/A

Summary

FTC Solar beats Roth CH Acquisition IV on 7 of the 12 factors compared between the two stocks.

How does Roth CH Acquisition IV compare to Beam Global?

Beam Global (NASDAQ:BEEM) and Roth CH Acquisition IV (NASDAQ:ROCG) are both small-cap industrials companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, dividends, profitability, media sentiment, valuation, institutional ownership, analyst recommendations and earnings.

Roth CH Acquisition IV has a net margin of 0.00% compared to Beam Global's net margin of -64.60%. Beam Global's return on equity of -73.59% beat Roth CH Acquisition IV's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Beam Global	-64.60%	-73.59%	-41.43%
Roth CH Acquisition IV	N/A	-6,449.52%	-0.66%

Beam Global has a beta of 1.48, indicating that its stock price is 48% more volatile than the broader market. Comparatively, Roth CH Acquisition IV has a beta of 0.03, indicating that its stock price is 97% less volatile than the broader market.

26.6% of Beam Global shares are owned by institutional investors. Comparatively, 67.1% of Roth CH Acquisition IV shares are owned by institutional investors. 5.6% of Beam Global shares are owned by company insiders. Comparatively, 29.6% of Roth CH Acquisition IV shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Beam Global presently has a consensus target price of $1.50, suggesting a potential upside of 23.97%. Given Beam Global's stronger consensus rating and higher possible upside, research analysts plainly believe Beam Global is more favorable than Roth CH Acquisition IV.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Beam Global	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.25
Roth CH Acquisition IV	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Roth CH Acquisition IV has lower revenue, but higher earnings than Beam Global.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Beam Global	$28.24M	0.97	-$27M	-$0.82	N/A
Roth CH Acquisition IV	N/A	N/A	-$180K	N/A	N/A

In the previous week, Beam Global had 4 more articles in the media than Roth CH Acquisition IV. MarketBeat recorded 4 mentions for Beam Global and 0 mentions for Roth CH Acquisition IV. Beam Global's average media sentiment score of 0.33 beat Roth CH Acquisition IV's score of 0.00 indicating that Beam Global is being referred to more favorably in the media.

Company	Overall Sentiment
Beam Global	Neutral
Roth CH Acquisition IV	Neutral

Summary

Beam Global beats Roth CH Acquisition IV on 8 of the 13 factors compared between the two stocks.

Get Roth CH Acquisition IV News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ROCG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ROCG vs. The Competition

Export

Metric	Roth CH Acquisition IV	Electrical Equipment Industry	Industrials Sector	NASDAQ Exchange
Market Cap	$13.21M	$10.67B	$10.33B	$13.29B
Dividend Yield	N/A	2.34%	96.94%	12.57%
P/E Ratio	N/A	44.91	25.23	25.76
Price / Sales	N/A	1,597.95	288.08	86.81
Price / Cash	N/A	34.05	24.10	52.76
Price / Book	-14.83	7.26	4.83	6.34
Net Income	-$180K	$139.67M	$613.71M	$360.00M
7 Day Performance	-13.59%	-0.51%	0.17%	-0.11%
1 Month Performance	-18.35%	-2.93%	-2.79%	-3.42%
1 Year Performance	-58.99%	-0.22%	3.77%	5.46%

Roth CH Acquisition IV Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ROCG Roth CH Acquisition IV	N/A	$0.89 -8.7%	N/A	-55.1%	$13.21M	N/A	N/A	126	High Trading Volume
STI Solidion Technology	1.3918 of 5 stars	$7.03 -2.8%	N/A	+47.5%	$59.83M	$10K	N/A	N/A	Buyback Announcement Short Interest Decrease Gap Down
WBX Wallbox	4.5544 of 5 stars	$3.11 -6.0%	$4.33 +39.3%	-39.8%	$53.27M	$164.15M	N/A	1,108
NMAD Lixte Biotechnology	0.7278 of 5 stars	$3.27 -7.6%	N/A	-32.4%	$52.65M	N/A	N/A	4	Gap Up
FTCI FTC Solar	3.2717 of 5 stars	$2.21 -3.9%	$10.50 +375.1%	-64.2%	$36.51M	$99.69M	N/A	220	Analyst Forecast Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ROCG) was last updated on 9/24/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Roth CH Acquisition IV (ROCG) Competitors

ROCG vs. STI, WBX, NMAD, FTCI, and BEEM

How does Roth CH Acquisition IV compare to Solidion Technology?

Summary

How does Roth CH Acquisition IV compare to Wallbox?

Summary

How does Roth CH Acquisition IV compare to Lixte Biotechnology?

Summary

How does Roth CH Acquisition IV compare to FTC Solar?

Summary

How does Roth CH Acquisition IV compare to Beam Global?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ROCG vs. The Competition

Roth CH Acquisition IV Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Roth CH Acquisition IV (ROCG) Competitors

ROCG vs. STI, WBX, NMAD, FTCI, and BEEM

How does Roth CH Acquisition IV compare to Solidion Technology?

Is ROCG or STI more profitable?

Do analysts rate ROCG or STI?

Does the media refer more to ROCG or STI?

Which has more risk and volatility, ROCG or STI?

Do insiders & institutionals hold more shares of ROCG or STI?

Which has preferable valuation & earnings, ROCG or STI?

Summary

How does Roth CH Acquisition IV compare to Wallbox?

Do analysts recommend ROCG or WBX?

Which has more risk & volatility, ROCG or WBX?

Do insiders and institutionals have more ownership in ROCG or WBX?

Which has better valuation & earnings, ROCG or WBX?

Is ROCG or WBX more profitable?

Does the media prefer ROCG or WBX?

Summary

How does Roth CH Acquisition IV compare to Lixte Biotechnology?

Do analysts recommend NMAD or ROCG?

Do insiders & institutionals believe in NMAD or ROCG?

Is NMAD or ROCG more profitable?

Does the media favor NMAD or ROCG?

Which has stronger valuation & earnings, NMAD or ROCG?

Which has more risk and volatility, NMAD or ROCG?

Summary

How does Roth CH Acquisition IV compare to FTC Solar?

Do insiders and institutionals hold more shares of ROCG or FTCI?

Is ROCG or FTCI more profitable?

Does the media prefer ROCG or FTCI?

Which has more risk and volatility, ROCG or FTCI?

Do analysts rate ROCG or FTCI?

Which has higher valuation and earnings, ROCG or FTCI?

Summary

How does Roth CH Acquisition IV compare to Beam Global?

Is BEEM or ROCG more profitable?

Which has more volatility & risk, BEEM or ROCG?

Do insiders & institutionals hold more shares of BEEM or ROCG?

Do analysts recommend BEEM or ROCG?

Which has stronger valuation and earnings, BEEM or ROCG?

Does the media prefer BEEM or ROCG?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ROCG vs. The Competition

Roth CH Acquisition IV Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools